Form 4 holding
Director
AGIOS PHARMACEUTICALS, INC.
- Security class
- Common stock
- Shares / value
- 15,230
- Estimated value
- $515,230
- Report date
- 18 Jun 2026
- Price
- $33.83
- Ownership
- Direct
Rahul D. Ballal - Director at AGIOS PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- AGIO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Rahul D. Ballal since 20 Aug 2025
Reported holdings for Rahul D. Ballal in AGIOS PHARMACEUTICALS, INC.
Form 4 holding
Director
AGIOS PHARMACEUTICALS, INC.
- Security class
- Restricted stock units
- Shares / value
- 2,927
- Estimated value
- $98,411
- Report date
- 18 Jun 2026
- Price
- $42.75
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Form 4 holding
Director
AGIOS PHARMACEUTICALS, INC.
- Security class
- Stock option (right to buy)
- Shares / value
- 17,947
- Estimated value
- Report date
- 08 Nov 2024
- Price
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Form 4 holding
Director
AGIOS PHARMACEUTICALS, INC.
- Security class
- Stock options (right to buy)
- Shares / value
- 14,950
- Estimated value
- Report date
- 18 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Transaction history for Rahul D. Ballal in AGIOS PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.